20
total announcements
CAMLINFINE.NS · 15 min delayed
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the transcript of the conference call on the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has published un-audited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 219 crores, with a basic EPS of Rs. 0.31 and a diluted EPS of Rs. 0.31.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the link of recording of the conference call on the un-audited financial results for the quarter ended June 30, 2026. The audio recording is available on the company's website.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has released its investor presentation for Q1FY27, highlighting a 28% increase in revenue to Rs. 5,199 mn, with EBITDA margin at 3.4% and PAT at Rs. 10 mn. The company expects growth momentum to continue despite higher raw material prices and logistics costs.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a standalone profit/loss of ₹123.12 crore and a consolidated profit/loss of ₹-336.22 crore.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited held its 33rd Annual General Meeting on August 11, 2026, through video conferencing. The meeting was conducted in compliance with the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The shareholders approved all the items of business contained in the AGM Notice, and the voting results were made available on the company's website.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a scheduled conference call with investors and analysts to discuss the Un-audited financial results for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the dispatch of notice of its 33rd Annual General Meeting through video conferencing.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about letters sent to Shareholders regarding the Annual Report 2025-26 and the 33rd Annual General Meeting (AGM) scheduled for August 11, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026, to consider and adopt audited financial statements for FY 2025-26, re-appointment of directors, and other business.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a copy of newspaper publication related to the 33rd Annual General Meeting of the company.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has completed the simplified cash tender offer for the remaining shares of Vinpai, acquiring 95.41% of the share capital and 91.46% of the theoretical voting rights. The company will not request a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding the resignation of Mr. Anvarhusen Bilakhiya as Senior Management Personnel of the company, effective July 7, 2026, due to personal commitments.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has received a declaration from Ashish Dandekar, the promoter and promoter group of the company, under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration states that the promoter group has not made any encumbrance on the shares of the company held by them, directly or indirectly, other than those already disclosed during the financial year ended March 31, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about an update on an analyst/institutional investor meeting, stating that company officials interacted with investors/analysts on July 1, 2026, in Mumbai, discussing publicly available information and no unpublished price-sensitive information was shared.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a scheduled meet with investors/analysts on July 1, 2026, in Mumbai. The discussions will be based on publicly available information and no unpublished price-sensitive information will be shared.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the shares of the Company shall remain closed from July 1, 2026 till 48 hours after the declaration of Un-audited Standalone and Consolidate Financial Results for the quarter ended June 30, 2026 for Designated Persons and their immediate relatives.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a press release issued by the Company regarding the clearance decision of the French stock market authority for the mandatory tender offer by the Company for Vinpai shares, along with the release of the offer document and other information document.